CIK 0000811641
- Non-accelerated filer
- Smaller reporting company
IMMUCELL CORP /DE/
Sign in to watch- Ticker
- ICCC
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010382980
- Phone
- +1 207-878-2770
- Business address
- 56 EVERGREEN DR, PORTLAND, ME, 04103
- 4 Open-market buy Director bought 715 shares at $3.39 ($2,424)
- 4 Open-market buy Director bought 2,062 shares at an average $3.59 ($7,406)
- 4 Open-market buy Director bought 700 shares at an average $3.38 ($2,369)
- 4 Open-market buy Director bought 1,102 shares at an average $3.02 ($3,326)
- 4 Open-market buy Director bought 3,800 shares at an average $3.06 ($11,634)
- 4 Open-market buy Director bought 1,000 shares at an average $3.31 ($3,305)
- 4 Open-market buy Vice President & CSO bought 1,000 shares at $3.50 ($3,500)
- 4 Open-market buy President & CEO bought 388 shares at $3.27 ($1,269)
- 4 Open-market buy President & CEO bought 612 shares at $3.27 ($2,001)
- 4 Open-market buy Director bought 3,296 shares at an average $3.55 ($11,692)
- 4 Open-market buy Director bought 3,355 shares at an average $3.42 ($11,460)
- 4 Open-market buy Director bought 1,600 shares at an average $3.69 ($5,898)
- 4 Open-market buy Director bought 1,000 shares at $4.00 ($4,000)
- 4 Open-market buy Director bought 350 shares at $4.43 ($1,551)
- 4 Open-market buy Director bought 5,975 shares at an average $3.96 ($23,669)
- 4 Open-market buy Director bought 1,400 shares at $3.93 ($5,502)
- 4 Open-market buy Director bought 13,340 shares at an average $3.95 ($52,679)
- 4 Open-market buy Director bought 1,600 shares at an average $3.69 ($5,910)
- 4 Open-market buy Vice President & CSO bought 500 shares at $3.74 ($1,870)
- 4 Open-market buy President & CEO bought 500 shares at $3.74 ($1,870)
Page 10 of 13 · 256 filings